首页> 外国专利> MOUSE LYMPHOCYTE HYBRIDOMA THAT PRODUCTS ANTIBODY AGAINST HUMAN PLASMA FIBRINOGEN AND ITS PROTEOLYTIC FRAGMENTS AND METHOD OF ITS PREPARATION

MOUSE LYMPHOCYTE HYBRIDOMA THAT PRODUCTS ANTIBODY AGAINST HUMAN PLASMA FIBRINOGEN AND ITS PROTEOLYTIC FRAGMENTS AND METHOD OF ITS PREPARATION

机译:产生抗人血浆纤维蛋白原抗体的小鼠淋巴细胞杂交体及其蛋白水解片段及其制备方法

摘要

The invention concerns a new murine lymphocyte hybridoma that produces a monoclonal antibody against human plasma fibrinogen and its proteolytic fragments. The murine lymphocyte hybridoma is prepared by immunisation of mice of the BALB/c strain with fibrinogen and its degradation products and subsequently fusing splenetic lymphocytes of the immunised mice with murine myelomal strain Sp-2/0-Ag14 or other murine myelomal strain. The selected and extracted hybridoma can serve for production of a monoclonal antibody against human plasma fibrinogen and its proteolytic fragments, which reacts, with unsplit plasma fibrinogen and with FDP. The monoclonal antibody produced in this way can serve the development of diagnostic systems for detection of human plasma fibrinogen in plasma and FDP in plasma and other biological fluids of ill people with various breakdowns in blood coagulation.
机译:本发明涉及一种新的鼠淋巴细胞杂交瘤,其产生抗人血浆纤维蛋白原及其蛋白水解片段的单克隆抗体。鼠淋巴细胞杂交瘤是通过用纤维蛋白原及其降解产物免疫BALB / c株的小鼠,然后将其与鼠骨髓株Sp-2 / 0-Ag14或其他鼠骨髓株融合的脾淋巴细胞融合而制备的。选择并提取的杂交瘤可用于产生抗人血浆纤维蛋白原及其蛋白水解片段的单克隆抗体,其与未分裂的血浆纤维蛋白原和FDP反应。以这种方式产生的单克隆抗体可用于诊断系统的开发,以检测血浆中人血浆纤维蛋白原以及患有各种凝血功能障碍的患者血浆和其他生物液体中的FDP。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号